Trial Profile
A study of fosmidomycin and piperaquine combination in children (1 to 5 years of age) in sub-Saharan Africa.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Fosmidomycin (Primary) ; Piperaquine (Primary)
- Indications Falciparum malaria
- Focus Adverse reactions; Pharmacodynamics
- 06 Oct 2016 New trial record